Diabetes Pro Quarterly - Winter 2018 - 4

CLINICAL NEWS

Clinical Diabetes Issue Highlights Patient-Centered
Diabetes Care
Clinical Diabetes recently published a special issue on patient-centered diabetes care.
Patient-centered care is an approach to providing medical care that is respectful of and
responsive to individual patients' preferences, needs, and values. Articles in this special
issue of Clinical Diabetes examine patient-centered diabetes care and topics such as
patient empowerment, medication adherence, diet and exercise goal attainment, mindfulness for pain relief, diabetes self-management and support, mental illness, individualization of A1C goals and medication regimens, and reducing barriers to and disparities
in care. The patient-centered diabetes care issue of Clinical Diabetes is available at
clinical.diabetesjournals.org/content/35/5.

Diabetes Care Topic Collection Focuses on Heart Failure
The January issue of Diabetes Care includes several articles investigating diabetes and
heart failure. Articles in this topic collection include original research on diabetes and
cardiovascular complications from the GERODIAB study, the prognostic significance
of preserved ejection fraction, changes in short- and long-term prognosis over the past
few decades, and mortality reduction associated with β-adrenoceptor inhibition. Other
important contributions to this issue include an in-depth discussion of cardiovascular
outcomes trials in type 2 diabetes from the Diabetes Care Editors' Expert Forum, as well
as a Commentary discussing the relationship between diabetes and heart failure. This
collection of articles from the January issue of Diabetes Care is available at care.
diabetesjournals.org/collection/heart-failure.

Diabetes Care Special Section Explores Progress in
Continuous Glucose Monitoring
The December 2017 issue of Diabetes Care featured a special section exploring progress
in continuous glucose monitoring (CGM) and its implications for clinical care and research. Included is a joint Scientific Statement from the American Diabetes Association
and the European Association for the Study of Diabetes on clinical evidence regarding
CGM use, currently available systems, and practical issues such as patient education and
safety. Also included are two expert Consensus Reports; the first reviews evidence on
how best to use CGM to improve patient care and research and emphasizes the need for
standardized data reporting, and the second defines measures of glycemic control other
than A1C, including categories of hypoglycemia and proportions of time in glucose target ranges during CGM. In addition, several related articles about the clinical utility of
CGM are included, as well as a Commentary advocating a more stringent definition of
severe hypoglycemia. This special section can be accessed from the Online Collections
page at care.diabetesjournals.org/collection/continuous-glucose-monitoring-andrisk-hypoglycemia.

Standards continued from page 2
* A new section describes emerging
evidence that speciﬁc glucose-lowering
medications delay the onset and progression of kidney disease (section 10,
p. S108).
* A detailed table highlighting the components of a comprehensive medical
evaluation has been redesigned and
reorganized. It incorporates information about the recommended frequency
of the components of care at both initial
and follow-up visits, including regular
screening for mental health (section 3,
p. S30, Table 3.1).
The Standards of Care are established and
revised annually by ADA's Professional
Practice Committee (PPC). The committee is a multidisciplinary team of 12
leading experts in the field of diabetes
care and includes physicians, diabetes
educators, registered dietitians, and
others whose experience includes adult
and pediatric endocrinology, epidemiology, public health, lipid research, hypertension, preconception planning, and
pregnancy care. For the 2018 Standards
of Care, two designated representatives
from the American College of Cardiology
reviewed and provided feedback for
the PPC's recommendations for cardiovascular disease and risk management.
Members of the committee must disclose
potential conflicts of interest with industry and/or relevant organizations; these
disclosures are available on pp. S154-
S155 of the 2018 Standards of Care. The
complete Standards of Care, an abridged
version of the Standards of Care designed
for primary care providers, and other
resources can be accessed for free online
at professional.diabetes.org/standards.

ADVOCACY NEWS

Is Your Patient Safe at School?
The parent of your patient is encountering resistance to writing
a 504 plan from her child's school. Your patient's school refuses
to let him participate in a field trip unless a parent accompanies
him. The varsity cheerleading squad of which your patient is a
member does not have a coach or other adult trained to recognize and treat hypoglycemia. Your patient's teacher has not been
instructed on what to do in the event that the student's continuous glucose monitoring device sounds an alarm. These are all
examples of discrimination against students with diabetes that is
prohibited by federal laws.
4

Want to learn more? Consider
hosting a Safe at School Brown
Bag Session so your team can
recognize discrimination when it
is happening and know where to
send patients' families for help.
For more information, contact Crystal Jackson, the American
Diabetes Association's director of Safe at School, at cjackson@
diabetes.org. Safe at School resources and information are
available at diabetes.org/safeatschool.

http://clinical.diabetesjournals.org/content/35/5 http://care.diabetesjournals.org/collection/heart-failure http://care.diabetesjournals.org/collection/heart-failure http://care.diabetesjournals.org/collection/continuous-glucose-monitoring-and-risk-hypoglycemia http://professional.diabetes.org/standards http://care.diabetesjournals.org/collection/continuous-glucose-monitoring-and-risk-hypoglycemia http://www.diabetes.org/safeatschool

Table of Contents for the Digital Edition of Diabetes Pro Quarterly - Winter 2018